News

Shares of Moderna Inc. fell over 2% on Wednesday after the U.S. Department of Health and Human Services (HHS) withdrew its ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
Moderna shares declined in February after Bloomberg reported that federal health officials were re-evaluating the company's $590 million contract to help develop a bird-flu vaccine. On Jan. 17, ...
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...